

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin A metabolic process (GO:0006776) | 7.77560670 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.49906052 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 7.39257691 |
| 4 | virion attachment to host cell (GO:0019062) | 7.26367847 |
| 5 | adhesion of symbiont to host cell (GO:0044650) | 7.26367847 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.52987987 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.21341676 |
| 8 | flavonoid metabolic process (GO:0009812) | 6.19085356 |
| 9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.13580146 |
| 10 | adhesion of symbiont to host (GO:0044406) | 6.03973793 |
| 11 | drug catabolic process (GO:0042737) | 5.89528472 |
| 12 | phospholipid efflux (GO:0033700) | 5.82309563 |
| 13 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.72866983 |
| 14 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.66518963 |
| 15 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.66518963 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 5.60493486 |
| 17 | regulation of triglyceride catabolic process (GO:0010896) | 5.58098130 |
| 18 | actin filament depolymerization (GO:0030042) | 5.52421136 |
| 19 | modified amino acid transport (GO:0072337) | 5.46312555 |
| 20 | fructose metabolic process (GO:0006000) | 5.38469133 |
| 21 | plasma lipoprotein particle assembly (GO:0034377) | 5.26218904 |
| 22 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.11018731 |
| 23 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.11018731 |
| 24 | protein-lipid complex assembly (GO:0065005) | 5.02870296 |
| 25 | regulation of cellular extravasation (GO:0002691) | 5.00217373 |
| 26 | cholesterol efflux (GO:0033344) | 4.87627738 |
| 27 | lipoprotein metabolic process (GO:0042157) | 4.82537435 |
| 28 | drinking behavior (GO:0042756) | 4.77140406 |
| 29 | regulation of bile acid biosynthetic process (GO:0070857) | 4.76569687 |
| 30 | * digestive system process (GO:0022600) | 4.70015763 |
| 31 | hormone catabolic process (GO:0042447) | 4.53663967 |
| 32 | regulation of cGMP biosynthetic process (GO:0030826) | 4.51588472 |
| 33 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.50917481 |
| 34 | glucose 6-phosphate metabolic process (GO:0051156) | 4.48923485 |
| 35 | purine nucleotide salvage (GO:0032261) | 4.46393992 |
| 36 | peptide hormone processing (GO:0016486) | 4.44055352 |
| 37 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.43701782 |
| 38 | digestion (GO:0007586) | 4.39528197 |
| 39 | diacylglycerol metabolic process (GO:0046339) | 4.32450538 |
| 40 | peptide catabolic process (GO:0043171) | 4.24696644 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.24554967 |
| 42 | cholesterol transport (GO:0030301) | 4.20523814 |
| 43 | sterol transport (GO:0015918) | 4.20523814 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.18120786 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.18120786 |
| 46 | sulfate transmembrane transport (GO:1902358) | 4.12347088 |
| 47 | cholesterol homeostasis (GO:0042632) | 4.10794880 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.10117784 |
| 49 | antibacterial humoral response (GO:0019731) | 4.08169972 |
| 50 | lipoprotein transport (GO:0042953) | 4.07971375 |
| 51 | sterol homeostasis (GO:0055092) | 4.07297079 |
| 52 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.07123712 |
| 53 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.06466087 |
| 54 | cellular glucuronidation (GO:0052695) | 4.05867580 |
| 55 | renal system process involved in regulation of blood volume (GO:0001977) | 4.02870435 |
| 56 | response to hepatocyte growth factor (GO:0035728) | 4.02808418 |
| 57 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.02808418 |
| 58 | antimicrobial humoral response (GO:0019730) | 4.02608741 |
| 59 | uronic acid metabolic process (GO:0006063) | 4.00746022 |
| 60 | glucuronate metabolic process (GO:0019585) | 4.00746022 |
| 61 | transepithelial transport (GO:0070633) | 3.98865680 |
| 62 | bile acid and bile salt transport (GO:0015721) | 3.93087567 |
| 63 | glycolipid catabolic process (GO:0019377) | 3.81348718 |
| 64 | glycosphingolipid catabolic process (GO:0046479) | 3.77341362 |
| 65 | cellular response to nitric oxide (GO:0071732) | 3.76498324 |
| 66 | sulfur compound transport (GO:0072348) | 3.76377045 |
| 67 | regulation of vitamin metabolic process (GO:0030656) | 3.74921887 |
| 68 | vitamin transmembrane transport (GO:0035461) | 3.74413673 |
| 69 | regulation of cGMP metabolic process (GO:0030823) | 3.72022816 |
| 70 | thyroid hormone metabolic process (GO:0042403) | 3.70145412 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.67979307 |
| 72 | bicarbonate transport (GO:0015701) | 3.64009747 |
| 73 | high-density lipoprotein particle remodeling (GO:0034375) | 3.62944522 |
| 74 | sulfation (GO:0051923) | 3.61182376 |
| 75 | positive regulation of pseudopodium assembly (GO:0031274) | 3.56820438 |
| 76 | response to hydroperoxide (GO:0033194) | 3.55645167 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 3.55071437 |
| 78 | alkaloid metabolic process (GO:0009820) | 3.51185908 |
| 79 | NADH metabolic process (GO:0006734) | 3.49540656 |
| 80 | homocysteine metabolic process (GO:0050667) | 3.49138317 |
| 81 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.48591979 |
| 82 | vitamin transport (GO:0051180) | 3.46665497 |
| 83 | drug transport (GO:0015893) | 3.46062608 |
| 84 | sperm capacitation (GO:0048240) | 3.46020937 |
| 85 | oligosaccharide catabolic process (GO:0009313) | 3.45925710 |
| 86 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.45720052 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 3.45537848 |
| 88 | macromolecular complex remodeling (GO:0034367) | 3.45537848 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45537848 |
| 90 | cGMP-mediated signaling (GO:0019934) | 3.44292333 |
| 91 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.41373505 |
| 92 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.40646908 |
| 93 | endocrine process (GO:0050886) | 3.40646908 |
| 94 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.40646908 |
| 95 | negative regulation of digestive system process (GO:0060457) | 3.38617855 |
| 96 | fat-soluble vitamin metabolic process (GO:0006775) | 3.37864325 |
| 97 | cellular carbohydrate catabolic process (GO:0044275) | 3.37000851 |
| 98 | response to nitric oxide (GO:0071731) | 3.36975286 |
| 99 | cellular response to reactive nitrogen species (GO:1902170) | 3.35673918 |
| 100 | regulation of digestive system process (GO:0044058) | 3.34484562 |
| 101 | response to phenylpropanoid (GO:0080184) | 3.34195881 |
| 102 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.33923638 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.32728620 |
| 104 | regulation of lipoprotein metabolic process (GO:0050746) | 3.31966198 |
| 105 | sulfate transport (GO:0008272) | 3.31795331 |
| 106 | protein-lipid complex subunit organization (GO:0071825) | 3.31654608 |
| 107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.31541947 |
| 108 | polyol transport (GO:0015791) | 3.31002760 |
| 109 | arginine metabolic process (GO:0006525) | 3.28938638 |
| 110 | sphingomyelin metabolic process (GO:0006684) | 3.28552095 |
| 111 | nucleobase catabolic process (GO:0046113) | 3.27828246 |
| 112 | regulation of penile erection (GO:0060405) | 3.24286416 |
| 113 | regulation of pseudopodium assembly (GO:0031272) | 3.22789693 |
| 114 | cGMP biosynthetic process (GO:0006182) | 3.22125063 |
| 115 | transcytosis (GO:0045056) | 3.21850726 |
| 116 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.21700726 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 3.18623149 |
| 118 | auditory receptor cell differentiation (GO:0042491) | 3.17606790 |
| 119 | innate immune response in mucosa (GO:0002227) | 3.17366676 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.16789219 |
| 121 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.15659032 |
| 122 | sexual reproduction (GO:0019953) | 3.14671351 |
| 123 | exogenous drug catabolic process (GO:0042738) | 3.14429871 |
| 124 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.14194512 |
| 125 | hydrogen peroxide catabolic process (GO:0042744) | 3.12621418 |
| 126 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.11868687 |
| 127 | drug metabolic process (GO:0017144) | 3.11809859 |
| 128 | ceramide catabolic process (GO:0046514) | 3.11457938 |
| 129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.09017189 |
| 130 | glycosylceramide metabolic process (GO:0006677) | 3.08735022 |
| 131 | vitamin biosynthetic process (GO:0009110) | 3.07563185 |
| 132 | positive regulation of respiratory burst (GO:0060267) | 3.05970759 |
| 133 | bile acid metabolic process (GO:0008206) | 3.03962719 |
| 134 | drug transmembrane transport (GO:0006855) | 3.02401943 |
| 135 | sphingolipid catabolic process (GO:0030149) | 3.00531036 |
| 136 | mRNA modification (GO:0016556) | 3.00246100 |
| 137 | histamine secretion (GO:0001821) | 2.99134350 |
| 138 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.98888139 |
| 139 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.98816145 |
| 140 | urea metabolic process (GO:0019627) | 2.98491813 |
| 141 | urea cycle (GO:0000050) | 2.98491813 |
| 142 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97745266 |
| 143 | regulation of sterol transport (GO:0032371) | 2.96404728 |
| 144 | regulation of cholesterol transport (GO:0032374) | 2.96404728 |
| 145 | glycerol metabolic process (GO:0006071) | 2.96085010 |
| 146 | regulation of systemic arterial blood pressure (GO:0003073) | 2.95491995 |
| 147 | cobalamin metabolic process (GO:0009235) | 2.93829915 |
| 148 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.93567164 |
| 149 | phenol-containing compound catabolic process (GO:0019336) | 2.92577447 |
| 150 | glomerulus development (GO:0032835) | 2.91741374 |
| 151 | sodium ion homeostasis (GO:0055078) | 2.89058539 |
| 152 | midgut development (GO:0007494) | 2.88740587 |
| 153 | leukotriene metabolic process (GO:0006691) | 2.87433953 |
| 154 | intestinal cholesterol absorption (GO:0030299) | 12.1017803 |
| 155 | angiotensin maturation (GO:0002003) | 11.4446287 |
| 156 | * intestinal absorption (GO:0050892) | 11.1867606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.60574032 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.21647507 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.54682680 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.52162261 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.13702402 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.02865903 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.91892935 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.79296658 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.70491820 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66049379 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.65124391 |
| 12 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.58025433 |
| 13 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.53000578 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50479683 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24463101 |
| 16 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.12066748 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09673199 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.05445428 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.82164387 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75899486 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70184336 |
| 22 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.68437533 |
| 23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68274330 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64536320 |
| 25 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.64297468 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.64272909 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61812042 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59236385 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56069598 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55868829 |
| 31 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50311753 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48199945 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47322472 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45991125 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42104910 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41242494 |
| 37 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41224011 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40072876 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37247206 |
| 40 | GATA2_19941826_ChIP-Seq_K562_Human | 1.37051949 |
| 41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35885473 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35181299 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.33151183 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29831467 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27566591 |
| 46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25648108 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24669278 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24317449 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23644474 |
| 50 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21606435 |
| 51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20895557 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18876823 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17988433 |
| 54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16625257 |
| 55 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16303555 |
| 56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16240692 |
| 57 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.14223285 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13471481 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13273234 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07923590 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05861914 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04730125 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02464994 |
| 64 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97570895 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97113174 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97104380 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96091906 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94598086 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91775583 |
| 70 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90287780 |
| 71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90157766 |
| 72 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.89560382 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89424594 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89128831 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88970487 |
| 76 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88952282 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88316215 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88228832 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87751183 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.87552575 |
| 81 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87134866 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85974022 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85782153 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85782153 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85258496 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85094914 |
| 87 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84197859 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84162767 |
| 89 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84112948 |
| 90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83624538 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83215486 |
| 92 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82476526 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82060633 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81954709 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81880920 |
| 96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.81867385 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81611607 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81579051 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81434068 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80757148 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80748304 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.79907675 |
| 103 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79199209 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79154355 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.79047594 |
| 106 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.78759043 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78583421 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78313422 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78279035 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78226280 |
| 111 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.77944419 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77519267 |
| 113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76985809 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76704831 |
| 115 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76493104 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76440167 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76420228 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76420228 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.75787548 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75613323 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75610076 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75366986 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75200117 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75012719 |
| 125 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74298065 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72793067 |
| 127 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72554012 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72471369 |
| 129 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.71277898 |
| 130 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.71253040 |
| 131 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69217982 |
| 132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.68976787 |
| 133 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.68859956 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.68284319 |
| 135 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67861075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 5.97152978 |
| 2 | MP0003183_abnormal_peptide_metabolism | 4.28748512 |
| 3 | MP0009840_abnormal_foam_cell | 4.20954625 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.85420713 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.85164871 |
| 6 | MP0003252_abnormal_bile_duct | 3.64603298 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.19909898 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.17632134 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.99558978 |
| 10 | MP0000462_abnormal_digestive_system | 2.89174619 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.70404224 |
| 12 | MP0003866_abnormal_defecation | 2.43739467 |
| 13 | MP0005409_darkened_coat_color | 2.33591824 |
| 14 | MP0004147_increased_porphyrin_level | 2.31470580 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.18970361 |
| 16 | MP0004043_abnormal_pH_regulation | 2.14935412 |
| 17 | MP0005360_urolithiasis | 10.2804335 |
| 18 | MP0005670_abnormal_white_adipose | 1.97034970 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.96549123 |
| 20 | MP0005365_abnormal_bile_salt | 1.94740550 |
| 21 | MP0009697_abnormal_copulation | 1.93187942 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 1.89843463 |
| 23 | MP0002822_catalepsy | 1.72454351 |
| 24 | MP0000538_abnormal_urinary_bladder | 1.70165011 |
| 25 | MP0003868_abnormal_feces_composition | 1.67519228 |
| 26 | MP0000537_abnormal_urethra_morphology | 1.65243406 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 1.63059837 |
| 28 | MP0003878_abnormal_ear_physiology | 1.63059837 |
| 29 | MP0001664_abnormal_digestion | 1.60235601 |
| 30 | MP0005381_digestive/alimentary_phenotyp | 1.58999291 |
| 31 | MP0001663_abnormal_digestive_system | 1.58630328 |
| 32 | MP0002254_reproductive_system_inflammat | 1.53025126 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.51787253 |
| 34 | MP0002796_impaired_skin_barrier | 1.46575172 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.45818553 |
| 36 | MP0001873_stomach_inflammation | 1.45350089 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.44990840 |
| 38 | MP0001188_hyperpigmentation | 1.41354702 |
| 39 | MP0005448_abnormal_energy_balance | 1.41038053 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.36975216 |
| 41 | MP0000477_abnormal_intestine_morphology | 1.35994391 |
| 42 | MP0005332_abnormal_amino_acid | 1.32679259 |
| 43 | MP0004858_abnormal_nervous_system | 1.26685920 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.26628655 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.25788305 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.24209076 |
| 47 | MP0004782_abnormal_surfactant_physiolog | 1.21755661 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.18102842 |
| 49 | MP0006054_spinal_hemorrhage | 1.17694283 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.14015821 |
| 51 | MP0000490_abnormal_crypts_of | 1.13918208 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.12458824 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.10407978 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.06794662 |
| 55 | MP0005535_abnormal_body_temperature | 1.05020219 |
| 56 | MP0004484_altered_response_of | 1.01892671 |
| 57 | MP0000609_abnormal_liver_physiology | 0.99625449 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.94800141 |
| 59 | MP0008775_abnormal_heart_ventricle | 0.91877289 |
| 60 | MP0005501_abnormal_skin_physiology | 0.90648243 |
| 61 | MP0005451_abnormal_body_composition | 0.90416197 |
| 62 | MP0000467_abnormal_esophagus_morphology | 0.89421005 |
| 63 | MP0003718_maternal_effect | 0.88840012 |
| 64 | MP0004947_skin_inflammation | 0.86644994 |
| 65 | MP0005266_abnormal_metabolism | 0.86201004 |
| 66 | MP0010678_abnormal_skin_adnexa | 0.83493690 |
| 67 | MP0004270_analgesia | 0.82845891 |
| 68 | MP0001765_abnormal_ion_homeostasis | 0.80960943 |
| 69 | MP0001849_ear_inflammation | 0.79507298 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.79319404 |
| 71 | MP0008872_abnormal_physiological_respon | 0.78418424 |
| 72 | MP0001845_abnormal_inflammatory_respons | 0.78004634 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 0.77756080 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.76877527 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 0.76598272 |
| 76 | MP0005165_increased_susceptibility_to | 0.74001401 |
| 77 | MP0000516_abnormal_urinary_system | 0.73948623 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 0.73948623 |
| 79 | MP0009053_abnormal_anal_canal | 0.72368703 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.72287916 |
| 81 | MP0005330_cardiomyopathy | 0.72270690 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.72157715 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 0.70932558 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.70755645 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.70744235 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.70002363 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.69528686 |
| 88 | MP0003283_abnormal_digestive_organ | 0.68332200 |
| 89 | MP0000566_synostosis | 0.67238033 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.66114336 |
| 91 | MP0008004_abnormal_stomach_pH | 0.65899593 |
| 92 | MP0008469_abnormal_protein_level | 0.62197174 |
| 93 | MP0009785_altered_susceptibility_to | 0.59983753 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 0.59499161 |
| 95 | MP0005385_cardiovascular_system_phenoty | 0.59499161 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.58701472 |
| 97 | MP0000249_abnormal_blood_vessel | 0.58132408 |
| 98 | MP0001764_abnormal_homeostasis | 0.56677921 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.56339941 |
| 100 | MP0003953_abnormal_hormone_level | 0.55923044 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54786021 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.54547785 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.54196432 |
| 104 | MP0005174_abnormal_tail_pigmentation | 0.54093943 |
| 105 | MP0003724_increased_susceptibility_to | 0.54045028 |
| 106 | MP0005334_abnormal_fat_pad | 0.52374445 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.52136854 |
| 108 | MP0004085_abnormal_heartbeat | 0.51932292 |
| 109 | MP0003329_amyloid_beta_deposits | 0.51442208 |
| 110 | MP0005166_decreased_susceptibility_to | 0.51403237 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.51348605 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.51121263 |
| 113 | MP0002972_abnormal_cardiac_muscle | 0.50515538 |
| 114 | MP0009115_abnormal_fat_cell | 0.50426466 |
| 115 | MP0001881_abnormal_mammary_gland | 0.48024649 |
| 116 | MP0006138_congestive_heart_failure | 0.47745338 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.47521532 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.47327933 |
| 119 | MP0003879_abnormal_hair_cell | 0.47235350 |
| 120 | MP0004510_myositis | 0.47125799 |
| 121 | MP0000604_amyloidosis | 0.46088459 |
| 122 | MP0001191_abnormal_skin_condition | 0.45205750 |
| 123 | MP0000427_abnormal_hair_cycle | 0.43119414 |
| 124 | MP0000579_abnormal_nail_morphology | 0.41829348 |
| 125 | MP0000678_abnormal_parathyroid_gland | 0.41518867 |
| 126 | MP0003941_abnormal_skin_development | 0.40880593 |
| 127 | MP0005310_abnormal_salivary_gland | 0.39561459 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.38871892 |
| 129 | MP0001756_abnormal_urination | 0.38836800 |
| 130 | MP0000377_abnormal_hair_follicle | 0.37703911 |
| 131 | MP0000613_abnormal_salivary_gland | 0.37026718 |
| 132 | MP0002971_abnormal_brown_adipose | 0.36046927 |
| 133 | MP0000470_abnormal_stomach_morphology | 0.35993258 |
| 134 | MP0003315_abnormal_perineum_morphology | 0.33785190 |
| 135 | MP0008873_increased_physiological_sensi | 0.33742967 |
| 136 | MP0002078_abnormal_glucose_homeostasis | 0.33136060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 8.92845082 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.02395742 |
| 3 | Acanthocytosis (HP:0001927) | 7.28680289 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.10153859 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 6.68251700 |
| 6 | Hydroxyprolinuria (HP:0003080) | 6.03605336 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 6.03605336 |
| 8 | Malnutrition (HP:0004395) | 5.63149056 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 5.31267123 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.23046370 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 4.92091945 |
| 12 | Cupped ribs (HP:0000887) | 4.85952092 |
| 13 | Pigmentary retinal degeneration (HP:0001146) | 4.46354139 |
| 14 | Increased IgE level (HP:0003212) | 4.36533067 |
| 15 | Poikilocytosis (HP:0004447) | 4.21704638 |
| 16 | Mesangial abnormality (HP:0001966) | 4.18502180 |
| 17 | Fat malabsorption (HP:0002630) | 4.17455349 |
| 18 | Hyperglycinuria (HP:0003108) | 4.05920835 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.05328377 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.84490988 |
| 21 | Widely patent fontanelles and sutures (HP:0004492) | 3.73168766 |
| 22 | B lymphocytopenia (HP:0010976) | 3.60170511 |
| 23 | Abnormality of B cell number (HP:0010975) | 3.60170511 |
| 24 | Decreased circulating renin level (HP:0003351) | 3.53314454 |
| 25 | Potter facies (HP:0002009) | 3.34791911 |
| 26 | Facial shape deformation (HP:0011334) | 3.34791911 |
| 27 | * Chronic diarrhea (HP:0002028) | 3.20552519 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 3.19018910 |
| 29 | Gastrointestinal dysmotility (HP:0002579) | 3.17823018 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.13107854 |
| 31 | Xanthomatosis (HP:0000991) | 3.12930664 |
| 32 | Increased purine levels (HP:0004368) | 3.08391847 |
| 33 | Hyperuricemia (HP:0002149) | 3.08391847 |
| 34 | Rectal prolapse (HP:0002035) | 2.98076539 |
| 35 | Steatorrhea (HP:0002570) | 2.96193490 |
| 36 | Thyroiditis (HP:0100646) | 2.94937262 |
| 37 | Nephrolithiasis (HP:0000787) | 2.91151729 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.89607439 |
| 39 | Combined immunodeficiency (HP:0005387) | 2.87458664 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 2.85193845 |
| 41 | Alkalosis (HP:0001948) | 2.85059175 |
| 42 | Posterior subcapsular cataract (HP:0007787) | 2.82335187 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.81479682 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.81479682 |
| 45 | Reticulocytosis (HP:0001923) | 2.76073442 |
| 46 | Abnormality of renin-angiotensin system (HP:0000847) | 2.75102717 |
| 47 | Increased mean platelet volume (HP:0011877) | 2.74188960 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.74003419 |
| 49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69773013 |
| 50 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.66084786 |
| 51 | Abnormality of chloride homeostasis (HP:0011422) | 2.61715078 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.55093652 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.53607603 |
| 54 | Hypotension (HP:0002615) | 2.50444760 |
| 55 | Sudden death (HP:0001699) | 2.50437062 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.49729277 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.46640182 |
| 58 | Hyperactive renin-angiotensin system (HP:0000841) | 2.44820421 |
| 59 | Enlarged epiphyses (HP:0010580) | 2.42272287 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.41678912 |
| 61 | Abnormal biliary tract morphology (HP:0012440) | 2.40353379 |
| 62 | Eczematoid dermatitis (HP:0000976) | 2.37318199 |
| 63 | Hyperphosphatemia (HP:0002905) | 2.37236411 |
| 64 | Abnormal platelet volume (HP:0011876) | 2.37102913 |
| 65 | Wide cranial sutures (HP:0010537) | 2.36840584 |
| 66 | Focal segmental glomerulosclerosis (HP:0000097) | 2.36337465 |
| 67 | Gout (HP:0001997) | 2.36168636 |
| 68 | Polycythemia (HP:0001901) | 2.34062117 |
| 69 | Epidermoid cyst (HP:0200040) | 2.33651177 |
| 70 | * Dehydration (HP:0001944) | 2.32684934 |
| 71 | Bundle branch block (HP:0011710) | 2.31486060 |
| 72 | Goiter (HP:0000853) | 2.27829303 |
| 73 | Abnormality of the gastric mucosa (HP:0004295) | 2.27309812 |
| 74 | Villous atrophy (HP:0011473) | 2.26382019 |
| 75 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.26382019 |
| 76 | Woolly hair (HP:0002224) | 2.24307161 |
| 77 | Palpitations (HP:0001962) | 2.20267103 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 2.20125217 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19544043 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 2.18508030 |
| 81 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18150040 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.16333410 |
| 83 | * Abdominal distention (HP:0003270) | 2.15258254 |
| 84 | Delayed epiphyseal ossification (HP:0002663) | 2.12765964 |
| 85 | Protuberant abdomen (HP:0001538) | 2.12483373 |
| 86 | Abnormality of magnesium homeostasis (HP:0004921) | 2.12157707 |
| 87 | Abnormality of the costochondral junction (HP:0000919) | 2.10724667 |
| 88 | Subcapsular cataract (HP:0000523) | 2.10027921 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.09652568 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09652568 |
| 91 | Confusion (HP:0001289) | 2.06444995 |
| 92 | Abnormal urine phosphate concentration (HP:0012599) | 2.05303943 |
| 93 | Flat acetabular roof (HP:0003180) | 2.04628444 |
| 94 | Ventricular tachycardia (HP:0004756) | 2.04404078 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.03469610 |
| 96 | Pancreatitis (HP:0001733) | 2.02776141 |
| 97 | Glomerulonephritis (HP:0000099) | 1.97175835 |
| 98 | Proximal tubulopathy (HP:0000114) | 1.96821374 |
| 99 | Pustule (HP:0200039) | 1.96236774 |
| 100 | Nausea (HP:0002018) | 1.95998564 |
| 101 | Pili torti (HP:0003777) | 1.95987251 |
| 102 | Progressive sensorineural hearing impairment (HP:0000408) | 1.95971320 |
| 103 | Eosinophilia (HP:0001880) | 1.95759643 |
| 104 | Myopathic facies (HP:0002058) | 1.93971770 |
| 105 | Hyperammonemia (HP:0001987) | 1.93140076 |
| 106 | Complement deficiency (HP:0004431) | 1.93047972 |
| 107 | Hypoproteinemia (HP:0003075) | 1.92517936 |
| 108 | Syncope (HP:0001279) | 1.91890056 |
| 109 | Cerebral palsy (HP:0100021) | 1.91762062 |
| 110 | Skin nodule (HP:0200036) | 1.90339249 |
| 111 | Abnormality of complement system (HP:0005339) | 1.89537914 |
| 112 | Male infertility (HP:0003251) | 1.89204589 |
| 113 | Cheilitis (HP:0100825) | 1.87537237 |
| 114 | Ventricular arrhythmia (HP:0004308) | 1.86924710 |
| 115 | Gingivitis (HP:0000230) | 1.86753648 |
| 116 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.86659547 |
| 117 | Hyperparathyroidism (HP:0000843) | 1.86332236 |
| 118 | Milia (HP:0001056) | 1.86258503 |
| 119 | Megaloblastic anemia (HP:0001889) | 1.86046422 |
| 120 | Growth hormone excess (HP:0000845) | 1.85496155 |
| 121 | Renal tubular acidosis (HP:0001947) | 1.85105046 |
| 122 | Hyperbilirubinemia (HP:0002904) | 1.84930406 |
| 123 | Abnormal gallbladder physiology (HP:0012438) | 1.83666426 |
| 124 | Cholecystitis (HP:0001082) | 1.83666426 |
| 125 | Irritability (HP:0000737) | 1.82415071 |
| 126 | Thin bony cortex (HP:0002753) | 1.82211271 |
| 127 | Nephritis (HP:0000123) | 1.79707728 |
| 128 | Abnormal albumin level (HP:0012116) | 1.78263644 |
| 129 | Hypoalbuminemia (HP:0003073) | 1.78263644 |
| 130 | Glomerulosclerosis (HP:0000096) | 1.77350128 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.76971946 |
| 132 | Abnormal platelet function (HP:0011869) | 1.76971946 |
| 133 | Late onset (HP:0003584) | 1.76367681 |
| 134 | Exocrine pancreatic insufficiency (HP:0001738) | 1.75888853 |
| 135 | Metabolic alkalosis (HP:0200114) | 1.73452827 |
| 136 | * Metabolic acidosis (HP:0001942) | 1.73440244 |
| 137 | Hypophosphatemia (HP:0002148) | 1.72242802 |
| 138 | Abnormality of the 1st metacarpal (HP:0010009) | 1.70292933 |
| 139 | Symptomatic seizures (HP:0011145) | 1.68707303 |
| 140 | * Glycosuria (HP:0003076) | 1.67583739 |
| 141 | * Abnormality of urine glucose concentration (HP:0011016) | 1.67583739 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.67030974 |
| 143 | Granulocytopenia (HP:0001913) | 1.65651344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.56379372 |
| 2 | FRK | 7.55213849 |
| 3 | LMTK2 | 6.48118583 |
| 4 | MST4 | 5.35114877 |
| 5 | MST1R | 4.19084820 |
| 6 | PRKG2 | 3.32648295 |
| 7 | GRK6 | 3.00923034 |
| 8 | NME1 | 2.83794178 |
| 9 | AKT3 | 2.66276191 |
| 10 | EPHA2 | 2.41603605 |
| 11 | RIPK1 | 2.39039291 |
| 12 | EPHA3 | 2.26441084 |
| 13 | MAP3K10 | 2.22167409 |
| 14 | MAP3K2 | 2.12629675 |
| 15 | PTK6 | 1.99432491 |
| 16 | NUAK1 | 1.90496124 |
| 17 | ERN1 | 1.78809211 |
| 18 | MAP2K2 | 1.75166386 |
| 19 | MET | 1.53251938 |
| 20 | STK24 | 1.52133296 |
| 21 | EPHB2 | 1.51179355 |
| 22 | FGFR3 | 1.42046806 |
| 23 | MAP3K12 | 1.37486138 |
| 24 | TESK2 | 1.37392431 |
| 25 | TESK1 | 1.29465856 |
| 26 | NLK | 1.28253105 |
| 27 | STK10 | 1.19372251 |
| 28 | EPHA4 | 1.17170558 |
| 29 | LATS1 | 1.10667212 |
| 30 | CDC42BPA | 1.05353030 |
| 31 | DDR2 | 0.98496213 |
| 32 | TAOK1 | 0.93033455 |
| 33 | BMX | 0.91686387 |
| 34 | FER | 0.89407494 |
| 35 | PTK2 | 0.86209407 |
| 36 | PRKCI | 0.86196362 |
| 37 | IRAK1 | 0.86006887 |
| 38 | MAP3K7 | 0.85506978 |
| 39 | PDK2 | 0.83917328 |
| 40 | EPHB1 | 0.83506997 |
| 41 | MAP2K6 | 0.81971753 |
| 42 | MATK | 0.81026369 |
| 43 | STK39 | 0.78619768 |
| 44 | KSR2 | 0.78355451 |
| 45 | MAP3K11 | 0.76815244 |
| 46 | RIPK4 | 0.76623312 |
| 47 | TTK | 0.75254646 |
| 48 | OXSR1 | 0.75025414 |
| 49 | PRPF4B | 0.74663232 |
| 50 | ERBB2 | 0.74418583 |
| 51 | MAP3K8 | 0.73842948 |
| 52 | MYLK | 0.72727913 |
| 53 | PRKAA2 | 0.72714693 |
| 54 | CASK | 0.71267486 |
| 55 | SCYL2 | 0.71244683 |
| 56 | TAOK3 | 0.68338133 |
| 57 | PBK | 0.63951390 |
| 58 | PIK3CA | 0.61401425 |
| 59 | MAP3K3 | 0.60288222 |
| 60 | OBSCN | 0.60227345 |
| 61 | PAK4 | 0.60140914 |
| 62 | WNK4 | 0.54082551 |
| 63 | JAK1 | 0.53840314 |
| 64 | TBK1 | 0.53166135 |
| 65 | MAPK11 | 0.53111525 |
| 66 | PRKCZ | 0.50963194 |
| 67 | MAP3K1 | 0.49184149 |
| 68 | MAP2K1 | 0.48974204 |
| 69 | ICK | 0.48920712 |
| 70 | PDK4 | 0.48841423 |
| 71 | PDK3 | 0.48841423 |
| 72 | MAP3K9 | 0.48287661 |
| 73 | PDPK1 | 0.47768591 |
| 74 | PRKAA1 | 0.47415743 |
| 75 | DYRK1B | 0.47147931 |
| 76 | PIM2 | 0.46808617 |
| 77 | RET | 0.46031876 |
| 78 | GRK1 | 0.44520638 |
| 79 | CAMK2G | 0.44198755 |
| 80 | LRRK2 | 0.42082113 |
| 81 | PAK3 | 0.41554742 |
| 82 | YES1 | 0.40113136 |
| 83 | CAMK2B | 0.39597225 |
| 84 | TYK2 | 0.37849351 |
| 85 | PIM1 | 0.37277140 |
| 86 | BMPR2 | 0.35595490 |
| 87 | PRKCE | 0.35484255 |
| 88 | CDK6 | 0.34515262 |
| 89 | CAMK2A | 0.33863208 |
| 90 | DAPK2 | 0.33002179 |
| 91 | CSK | 0.32081070 |
| 92 | STK3 | 0.31595949 |
| 93 | JAK2 | 0.30355073 |
| 94 | PDK1 | 0.30354663 |
| 95 | ERBB4 | 0.30322053 |
| 96 | PRKACA | 0.30118640 |
| 97 | LIMK1 | 0.29852958 |
| 98 | PRKCA | 0.27192112 |
| 99 | ROCK1 | 0.26263613 |
| 100 | TGFBR2 | 0.25024080 |
| 101 | PRKD1 | 0.24148012 |
| 102 | SRC | 0.23976178 |
| 103 | IKBKE | 0.23288972 |
| 104 | ZAP70 | 0.23287698 |
| 105 | PDGFRA | 0.23088772 |
| 106 | MAPK7 | 0.22887589 |
| 107 | CSNK1A1 | 0.22665407 |
| 108 | ADRBK2 | 0.22509006 |
| 109 | PRKACG | 0.21726109 |
| 110 | IGF1R | 0.21640294 |
| 111 | TNIK | 0.20397719 |
| 112 | AKT2 | 0.19871202 |
| 113 | MAP3K5 | 0.19591385 |
| 114 | DMPK | 0.19591323 |
| 115 | IRAK3 | 0.18789938 |
| 116 | MAPKAPK2 | 0.18683742 |
| 117 | MELK | 0.18457690 |
| 118 | MAPKAPK3 | 0.18454694 |
| 119 | MAP3K6 | 0.18442861 |
| 120 | CDK12 | 0.18386122 |
| 121 | PKN2 | 0.17978450 |
| 122 | ITK | 0.17884731 |
| 123 | GSK3A | 0.17307684 |
| 124 | FGR | 0.17245725 |
| 125 | PRKCQ | 0.17152678 |
| 126 | FYN | 0.17149894 |
| 127 | INSRR | 0.16700919 |
| 128 | NEK1 | 0.14647918 |
| 129 | PRKCD | 0.14322674 |
| 130 | TYRO3 | 0.14290674 |
| 131 | MAP4K1 | 0.12936198 |
| 132 | FGFR4 | 0.12878022 |
| 133 | AURKB | 0.12471015 |
| 134 | PAK2 | 0.10854676 |
| 135 | STK11 | 0.09379484 |
| 136 | PAK1 | 0.09320782 |
| 137 | CAMK2D | 0.08576015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.11028991 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.69854581 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.60995388 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.29742827 |
| 5 | * Mineral absorption_Homo sapiens_hsa04978 | 3.70025003 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.96680245 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.86814599 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.80075713 |
| 9 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.48209671 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25995497 |
| 11 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.23908227 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.16257380 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.15092258 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.13313831 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.88313863 |
| 16 | * Bile secretion_Homo sapiens_hsa04976 | 1.76225945 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.72144349 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54285198 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.50393516 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41082831 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.40527949 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37469134 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.34932447 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31437528 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30778162 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.27287656 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24466756 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19832086 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15359916 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14982929 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14500872 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12978449 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.09325697 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09134194 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07402074 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.02111511 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.99719218 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99497944 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91300759 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85868043 |
| 41 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85012134 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77610539 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73097258 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71351794 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69645697 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68990876 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 0.67986987 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67079948 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64052597 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62682656 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60359490 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58882819 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58122311 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57467531 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56341638 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56107123 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55911712 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.54876706 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53560072 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53403948 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51586639 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50352836 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49098227 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44799584 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44794692 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42170901 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40866985 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40741267 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40550161 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.40268192 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39774658 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37575055 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36786798 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34781392 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33764603 |
| 76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33727467 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33074930 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31630908 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31192389 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.30767096 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30227810 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28692669 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25278438 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.23685093 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23477277 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23161883 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23119614 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.23032511 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21967846 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.21284577 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20988880 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.20803492 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20365775 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20155965 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.19548805 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.18038097 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17811518 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.17763574 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.17600091 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17224923 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17081147 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.16332167 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15250100 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15105408 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.14918699 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14300236 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14009836 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.13480823 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12930495 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12575939 |
| 111 | Renin secretion_Homo sapiens_hsa04924 | 0.12469373 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.12177740 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.11107133 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.11105641 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10034443 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09747765 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.09700266 |
| 118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.09539983 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.09070906 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.09045345 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07160959 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06970342 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.05635839 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.04329103 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.01269808 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.00878799 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.00626898 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0023060 |

